Skip to main content
Comprehensive health condition screening and monitoring with Myant Health

Comprehensive screening for the conditions that matter most

Our Textile Computing® platform enables continuous, multi-parameter monitoring to detect and manage a wide range of health conditions. From cardiac arrhythmias to sleep disorders, we provide the data you and your healthcare team need for proactive care.

Current and future screening capabilities

From a single garment, a holistic view of well-being

The human body is an interconnected system. Our Textile Computing® platform is uniquely designed to capture multiple biometrics concurrently, enabling Holistic Screening™ that creates a far more powerful and complete picture of patient health.

Stroke

795,000 (US) • 108,000 (Canada) • 9.5M (EU) • 7.3M (MENA)

Early detection through continuous cardiovascular monitoring and irregular heart rhythm identification. Stroke prevention relies on detecting precursor conditions like atrial fibrillation and hypertension.

  • Heart rate variability (HRV)
  • Atrial fibrillation detection
  • Blood pressure trends
  • Cerebrovascular indicators
Stroke
View clinical references
1

CDC. Stroke Facts. National Center for Chronic Disease Prevention and Health Promotion, 2024. WHO Global Stroke Statistics, 2023.

2

Hindricks G, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal, 2021;42(5):373-498.

3

Tsao CW, et al. Heart Disease and Stroke Statistics—2023 Update. Circulation. 2023;147:e93-e621. WHO Cardiovascular Disease Report, 2023.

4

Chaudhry SI, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363(24):2301-2309.

5

Kornej J, et al. Epidemiology of Atrial Fibrillation in the 21st Century. Circ Res. 2020;127(1):4-20. ESC AFib Statistics, 2023.

6

Steinhubl SR, et al. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation. JAMA. 2018;320(2):146-155.

7

Benjafield AV, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med. 2019;7(8):687-698.

8

Health Canada. Medical Device License #110765. Myant SKIIN™ Sleep Apnea Screening System, 2023.

All prevalence data represents diagnosed cases. Actual disease burden may be higher due to undiagnosed cases. Data sources accessed and verified as of 2024.